Spiriva Respimat

Spiriva Respimat

CVS logo
CVS
Pay Online$532.58
Walmart logo
Walmart
Pay Online$476.48
Walgreens logo
Walgreens
Pay Online$480.18
Albertsons logo
Albertsons
$521.15
Show this card to your pharmacist

Spiriva Respimat Savings card

$476.48

BIN
019876
ID
LH7BB28C7A
PCN
CHIPPO
GRP
LHX

Print or send this coupon to your phone

About Spiriva Respimat

Drug Details

Tiotropium, marketed as Spiriva, is a medication designed to manage chronic lung conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. It is particularly effective for individuals aged six and above. Tiotropium must be used regularly and consistently, as it works by relaxing the airway muscles to facilitate easier breathing, helping to prevent symptoms like wheezing and shortness of breath. It belongs to a category of medications known as anticholinergics or long-acting muscarinic antagonists (LAMA), which function by blocking specific receptors that tighten airway muscles. Spiriva is available in two forms: Spiriva Respimat, a metered-dose inhaler, and Spiriva HandiHaler, which involves placing a capsule into a device before inhalation. The typical dosage is two inhalations once daily, although this may vary based on individual treatment needs. It's important to note that Spiriva does not provide immediate relief for sudden breathing issues; for such situations, a quick-relief inhaler should be used as directed by a healthcare provider. Common side effects may include dry mouth, cough, and upper respiratory tract infections. A generic version is available for Spiriva HandiHaler. Always consult with a healthcare professional before starting any new medication.

Price history for Spiriva Respimat

1 Inhaler, 4GM of 2.5MCG/ACT

Average retail price for Spiriva Respimat

Average SaveHealth price for Spiriva Respimat

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Related Prescriptions

Spiriva Respimat dosage forms

DosageQuantityPrice fromPer unit
4GM of 2.5MCG/ACT1 Inhaler$476.48$476.48
4GM of 2.5MCG/ACT2 Inhalers$947.95$473.98
4GM of 2.5MCG/ACT3 Inhalers$1,419.43$473.14
4GM of 1.25MCG/ACT1 Inhaler$480.48$480.48
4GM of 1.25MCG/ACT2 Inhalers$955.95$477.98
4GM of 1.25MCG/ACT3 Inhalers$1,431.43$477.14

Spiriva Respimat FAQs

No, Spiriva Respimat is not a steroid inhaler. It contains tiotropium, which is a long-acting anticholinergic bronchodilator used to help open the airways in conditions like COPD and asthma.

The cost of a 30-day supply of Spiriva can vary depending on factors such as the pharmacy, location, and whether the patient has insurance coverage. Without insurance, the price can range from approximately $400 to $500. Patients are encouraged to check with their local pharmacy for the most accurate pricing and to inquire about any available discounts or patient assistance programs.

Yes, it is recommended to rinse the mouth after using Spiriva. This helps to remove any medication residue and can reduce the risk of developing oral thrush or irritation.

Spiriva and SPIRIVA RESPIMAT both contain the active ingredient tiotropium, which is used to manage chronic obstructive pulmonary disease (COPD) and asthma. The primary difference lies in their delivery systems. Spiriva is typically delivered via a dry powder inhaler called the HandiHaler, while SPIRIVA RESPIMAT uses a soft mist inhaler. The RESPIMAT device provides a fine mist that may be easier for some patients to inhale, especially those who have difficulty with dry powder inhalers.

If Spiriva is accidentally swallowed, it is unlikely to cause harm because it is intended for inhalation and has low systemic absorption when ingested. However, it may not provide the intended therapeutic effect for respiratory conditions. It is advisable to contact a healthcare provider for further guidance.

Read All FAQs